Basil Michelle L's Form 4 filing
Haemonetics Corp (HAE) · filed May 29, 2024
- Accession no.
- 0001127602-24-016810
- Filed
- May 29, 2024
- Trade date
- May 28-29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.14M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Basil Michelle LCIK 0001699629 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Common Stock | AGrant or awardAcquired | +24,748 | $0.00 | $0 | 56,005 | Direct | |
| May 28, 2024 | Common Stock | FTax withholdingDisposed | −11,758 | $95.73 | −$1,125,593.34 | 44,247 | Direct | |
| May 29, 2024 | Common Stock | SSaleDisposed | −8,896 | $87.86 | −$781,602.56 | 35,351 | Direct | |
| May 29, 2024 | Common Stock | SSaleDisposed | −4,094 | $88.57 | −$362,605.58 | 31,257 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.